SecurityBNFT / Benefitfocus, Inc. (08180D106)
President and CEOAugust Raymond Alexander
IndustryPrepackaged Software
Institutional Owners90
Institutional Shares29,943,711 - 94.27%
Common Shares Outstanding31,762,092 shares (as of 2018-03-31)
Institutional Value$ 2,322,526,000 USD

Institutional Stock Ownership and Shareholders

BNFT / Benefitfocus, Inc. Institutional Ownership

Benefitfocus, Inc. (NASDAQ:BNFT) has 90 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29,943,711 shares. Largest shareholders include Goldman Sachs Group Inc, Bamco Inc /ny/, FMR LLC / Fidelity, Frontier Capital Management Co Llc, Vanguard Group Inc, BlackRock Inc., Artisan Partners Limited Partnership, Discovery Group I, LLC, Arrowpoint Asset Management, LLC, and Credit Suisse Ag/.
Benefitfocus, Inc. (NASDAQ:BNFT) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/bnft"><img src="https://images.fintel.io/us-bnft-so.png" alt="BNFT / Benefitfocus, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 1,269 1,743 37.35 34 43 26.47
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 6,604 0 161
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 6,274,669 6,274,735 0.00 169,416 153,104 -9.63
2018-05-08 13F-HR US BANCORP \DE\ 1,992 49
2018-05-15 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC Call 15,700 0 -100.00 424 0 -100.00
2017-02-10 13F-HR BlackRock Advisors LLC 7,049 7,028 -0.30 281 209 -25.62
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 9,900 0 -100.00 267 0 -100.00
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 219,618 248,991 13.37 5,930 6,075 2.45
2018-05-14 13F-HR OAK RIDGE INVESTMENTS LLC 156,176 0 -100.00 4,217 0 -100.00
2018-04-23 13F-HR FIRST TRUST ADVISORS LP 16,831 0 -100.00 454 0 -100.00
2018-04-26 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 48,039 42,460 -11.61 1,297 1,036 -20.12
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 0 46,400 0 1,132
2018-05-15 13F-HR VANGUARD GROUP INC 1,655,183 1,628,868 -1.59 44,690 39,745 -11.07
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 10,705 10,159 -5.10 289 248 -14.19
2018-04-26 13F-HR SIMPLEX TRADING, LLC 437 0 -100.00 11 0 -100.00
2018-05-08 13F-HR FIRST MERCANTILE TRUST CO 3,628 11,626 220.45 98 284 189.80
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 13,700 334
2018-05-10 13F-HR Spark Investment Management LLC 41,361 120,100 190.37 1,116 2,930 162.54
2018-05-15 13F-HR BARCLAYS PLC 6,182 6,510 5.31 167 158 -5.39
2018-05-15 13F-HR Metlife Investment Advisors, Llc 6,419 6,419 0.00 173 157 -9.25
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 204,988 209,366 2.14 5,534 5,108 -7.70
2017-02-10 13F-HR BlackRock Investment Management, LLC 47,703 47,625 -0.16 1,904 1,414 -25.74
2018-05-10 13F-HR JP Morgan Chase & Co 3,428 3,199 -6.68 93 78 -16.13
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 318 1,565 392.14 9 38 322.22
2018-05-14 13F-HR TEACHERS ADVISORS INC 29,156 29,367 0.72 787 717 -8.89
2018-05-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 5,546 4,128 -25.57 150 100,723 67,048.67
2018-05-08 13F-HR TEACHER RETIREMENT SYSTEM OF TEXAS 48,286 46,430 -3.84 1,304 1,133 -13.11
2018-05-15 13F-HR PEAK6 Investments, L.P. 0 1,166 0 28
2018-05-11 13F-HR Elk Creek Partners, LLC 314,182 7,666
2017-02-10 13F-HR BlackRock Fund Advisors 325,556 381,366 17.14 12,996 11,327 -12.84
2018-05-15 13F-HR BlueCrest Capital Management Ltd 23,227 567
2018-05-14 13F-HR Renaissance Technologies LLC 0 10,550 0 257
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 227,298 227,298 0.00 6,137 5,546 -9.63
2018-04-30 13F-HR FRONTIER CAPITAL MANAGEMENT CO LLC 1,752,918 2,310,556 31.81 47,329 56,378 19.12
2018-05-09 13F-HR NORTHERN TRUST CORP 208,543 205,255 -1.58 5,631 5,008 -11.06
2018-05-08 13F-HR Aperio Group, LLC 8,864 15,139 70.79 239 369 54.39
2018-04-05 13F-HR RAYMOND JAMES TRUST N.A. 9,479 9,479 0.00 256 231 -9.77
2018-05-10 13F-HR Artisan Partners Limited Partnership 1,076,498 1,019,181 -5.32 29,065 24,868 -14.44
2018-05-15 13F-HR Invesco Ltd. 23,120 23,911 3.42 624 583 -6.57
2018-05-15 13F-HR UBS Group AG 8,104 8,104 0.00 219 198 -9.59
2018-05-15 13F-HR Arrowpoint Asset Management, LLC 689,102 717,355 4.10 18,606 17,503 -5.93
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 104,121 111,489 7.08 2,812 2,721 -3.24
2018-05-15 13F-HR Shannon River Fund Management LLC 0 181,600 0 4,431
2018-05-15 13F-HR Walleye Trading LLC Put 45,200 17,100 -62.17 1,221 417 -65.85
2018-05-07 13F-HR PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 46,550 54,550 17.19 1,257 1,331 5.89
2018-04-11 13F-HR GOFEN & GLOSSBERG LLC /IL/ 10,900 0 -100.00 294 0 -100.00
2018-05-15 13F-HR Intellectus Partners, LLC 200 200 0.00 5 5 0.00
2018-05-11 13F-HR MACQUARIE GROUP LTD 52,445 51,974 -0.90 1,416 1,268 -10.45
2018-05-15 13F-HR OAK MANAGEMENT CORP 630,378 630,378 0.00 17,020 15,381 -9.63
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 22,606 22,831 1.00 610 557 -8.69
2018-05-09 13F-HR GAGNON SECURITIES LLC 13,639 16,457 20.66 368 402 9.24
2018-05-14 13F-HR Royce & Associates LLC 95,198 111,398 17.02 2,570 2,718 5.76
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 310,023 313,355 1.07 8,370 7,646 -8.65
2018-05-15 13F-HR Walleye Trading LLC 0 1,895 0 46
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 1,372 1,372 0.00 37 33 -10.81
2018-05-11 13F-HR CITIGROUP INC 331 250 -24.47 9 6 -33.33
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 2,478 0 -100.00 67 0 -100.00
2018-05-15 13F-HR PDT Partners, LLC 60,067 60,403 0.56 1,622 1,474 -9.12
2018-05-09 13F-HR IFP Advisors, Inc 295 295 0.00 8 7 -12.50
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 52,399 55,847 6.58 1,414 1,363 -3.61
2018-05-03 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 380 380 0.00 10 9 -10.00
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 21,500 13,700 -36.28 581 334 -42.51
2018-05-17 13F-HR Legal & General Group Plc 4,047 2,805 -30.69 110 68 -38.18
2018-05-15 13F-HR Marshall Wace LLP 0 17,200 0 420
2018-05-08 13F-HR Bt Investment Management Ltd 42,388 57,322 35.23 1,144,476 1,398,657 22.21
2018-05-15 13F-HR Bank of New York Mellon Corp 72,035 75,344 4.59 1,945 1,839 -5.45
2018-05-15 13F-HR Walleye Trading LLC Call 34,200 21,600 -36.84 924 527 -42.97
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 1,395 1,395 0.00 38 34 -10.53
2018-05-14 13F-HR MORGAN STANLEY 330,838 35,053 -89.40 8,933 855 -90.43
2018-05-02 13F-HR RHUMBLINE ADVISERS 14,794 26,589 79.73 399 649 62.66
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 3,232 3,307 2.32 87,264 80,691 -7.53
2018-05-11 13F-HR Cutler Group LP Put 0 2,000 0 0
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 78,792 188,673 139.46 2,127 4,604 116.46
2018-05-15 13F-HR CREDIT SUISSE AG/ 305,006 714,688 134.32 8,235 17,439 111.77
2018-05-15 13F-HR PEAK6 Investments, L.P. Call 0 7,800 0 190
2018-05-11 13F-HR Cutler Group LP 1,034 100 -90.33 27 2 -92.59
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 9,675 9,776 1.04 261 239 -8.43
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 32,312 36,562 13.15 872 892 2.29
2018-04-23 13F-HR Whitener Capital Management, Inc. 50 50 0.00 1 1 0.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 38,852 22,857 -41.17 1,048 556 -46.95
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 12,836 12,673 -1.27 346 309 -10.69
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 3 24 700.00 0 0
2018-05-15 13F-HR ELLINGTON MANAGEMENT GROUP LLC 0 15,600 0 381
2018-05-04 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 17,382 17,382 0.00 469 424 -9.59
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 63 0 -100.00 0 0
2018-05-11 13F-HR CITADEL ADVISORS LLC 188,673 4,604
2018-05-10 13F-HR BAILLIE GIFFORD & CO 265,930 369,704 39.02 7,180 9,021 25.64
2017-02-10 13F-HR BlackRock Group LTD 6,283 6,703 6.68 251 199 -20.72
2018-05-14 13F-HR FMR LLC / Fidelity 4,690,683 4,058,952 -13.47 126,649 99,039 -21.80
2018-05-15 13F-HR PEAK6 Investments, L.P. Put 0 14,000 0 342
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 25,052 24,092 -3.83 676 588 -13.02
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 39,899 37,922 -4.96 1,077 925 -14.11
2018-05-15 13F-HR Wellington Management Group LLP 480,024 395,437 -17.62 12,961 9,648 -25.56
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 12,400 12,300 -0.81 335 300 -10.45
2018-05-04 13F-HR Swiss National Bank 25,600 27,200 6.25 691 664 -3.91
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 0 20,485 0 500
2018-04-11 13F-HR Capital Impact Advisors, LLC 39,394 0 -100.00 1,064 0 -100.00
2018-05-15 13F-HR BOARDMAN BAY CAPITAL MANAGEMENT LLC 86,850 160,001 84.23 2,345 3,904 66.48
2018-05-15 13F-HR STATE STREET CORP 308,542 314,924 2.07 8,331 7,680 -7.81
2017-11-13 13F-HR Discovery Group I, LLC 422,005 749,850 77.69 15,340 25,232 64.49
2018-05-15 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC Put 28,500 0 -100.00 770 0 -100.00
2018-05-09 13F-HR BlackRock Inc. 1,106,424 1,069,144 -3.37 29,874 26,087 -12.68
2017-02-14 13F-HR EverPoint Asset Management, LLC 135,000 245,000 81.48 5,389 7,277 35.03
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 29,200 29,200 0.00 788 712 -9.64
2018-04-16 13F-HR PEREGRINE CAPITAL MANAGEMENT LLC 644,503 614,280 -4.69 17,402 14,988 -13.87
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 105 0 -100.00 3 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 0 83,964 0 2,049
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 341,214 534,543 56.66 13,621 15,876 16.56
2018-05-09 13F-HR BAMCO INC /NY/ 4,145,968 4,173,603 0.67 111,941 101,836 -9.03

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

13h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Related News Stories

Benefitfocus' (BNFT) CEO Raymond August on Q1 2018 Results - Earnings Call Transcript

2018-05-04 seekingalpha
Greetings, and welcome to Benefitfocus Q1 2018 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Michael Bauer. (2-0)

Benefitfocus, Inc. 2017 Q4 - Results - Earnings Call Slides

2018-03-15 seekingalpha
The following slide deck was published by Benefitfocus, Inc. in conjunction with their 2017 Q4 earnings call. (2-0)

Benefitfocus' (BNFT) CEO Raymond August on Q4 2017 Results - Earnings Call Transcript

2018-03-15 seekingalpha
Greetings, and welcome to the Benefitfocus Q4 2017 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. (2-0)

CUSIP: 08180D106